Stonebridge Capital Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-245
| Closed | -$25.3K | – | 592 |
|
|
2023
Q3 | $25.3K | Hold |
245
| – | – | ﹤0.01% | 460 |
|
|
2023
Q2 | $29.8K | Hold |
245
| – | – | ﹤0.01% | 438 |
|
|
2023
Q1 | $37.6K | Sell |
245
-5
| -2% | -$768 | ﹤0.01% | 404 |
|
|
2022
Q4 | $44.9K | Hold |
250
| – | – | 0.01% | 369 |
|
|
2022
Q3 | $30K | Sell |
250
-1
| -0.4% | -$120 | ﹤0.01% | 408 |
|
|
2022
Q2 | $36K | Sell |
251
-32
| -11% | -$4.59K | ﹤0.01% | 400 |
|
|
2022
Q1 | $49K | Buy |
283
+125
| +79% | +$21.6K | 0.01% | 393 |
|
|
2021
Q4 | $40K | Buy |
158
+1
| +0.6% | +$253 | ﹤0.01% | 405 |
|
|
2021
Q3 | $60K | Sell |
157
-143
| -48% | -$54.7K | 0.01% | 329 |
|
|
2021
Q2 | $55K | Buy |
300
+150
| +100% | +$27.5K | ﹤0.01% | 445 |
|
|
2021
Q1 | $20K | Buy |
+150
| New | +$20K | ﹤0.01% | 504 |
|